Details of the Drug

General Information of Drug (ID: DM40551)

Drug Name

mRNA-1189

Indication

Disease Entry	ICD 11	Status	REF
Epstein barr virus infection	1C80	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Vaccine

Cross-matching ID

References

1	ClinicalTrials.gov (NCT05164094) A Phase 1, Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 12- to 30-Year-Old Healthy Adolescents and Adults. U.S.National Institutes of Health.